Aims Topical ciclosporin A (CsA) is a therapeutic option for dry eye disease (DED) to control ocular surface inflammation and improve tear function. The aim of this study is to systematically review ...

HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his allies may be in position to do something about it.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune‑mediated and metabolic diseases ...

Without treatment, these infections can lead to eye pain, vision problems, and in some cases, blindness. Parasites are organisms that live in, or on, another organism.

Texas has initiated a groundbreaking $50 million publicly funded research program to study ibogaine, a plant-based psychoactive compound, as a potential treatment for addiction.